Inhibition of endothelial progenitor cells may explain the high cardiovascular event rate in patients with rheumatoid arthritis

M Adawi^{1

2}, N Pastukh³, G Saaida², R Sirchan¹, A Watad⁴, A Blum^{1

2

3}

Affiliations

¹ From the Department of Medicine and the Rheumatology Unit, Baruch Padeh Medical Center, Bar Ilan University, Galilee, Israel.
² Azrieli Faculty of Medicine, Baruch Padeh Medical Center, Bar Ilan University, Galilee, Israel.
³ The Vascular Research Laboratory, Baruch Padeh Medical Center, Bar Ilan University, Galilee, Israel.
⁴ Department of Medicine 'B', The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.

Published Erratum

M Adawi et al. QJM. 2019.

. 2019 Feb 1;112(2):161.

doi: 10.1093/qjmed/hcy204.

M Adawi^{1

2}, N Pastukh³, G Saaida², R Sirchan¹, A Watad⁴, A Blum^{1

2

3}

¹ From the Department of Medicine and the Rheumatology Unit, Baruch Padeh Medical Center, Bar Ilan University, Galilee, Israel.
² Azrieli Faculty of Medicine, Baruch Padeh Medical Center, Bar Ilan University, Galilee, Israel.
³ The Vascular Research Laboratory, Baruch Padeh Medical Center, Bar Ilan University, Galilee, Israel.
⁴ Department of Medicine 'B', The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.

No abstract available

Erratum for

Inhibition of endothelial progenitor cells may explain the high cardiovascular event rate in patients with rheumatoid arthritis.
Adawi M, Pastukh N, Saaida G, Sirchan R, Watad A, Blum A. Adawi M, et al. QJM. 2018 Aug 1;111(8):525-529. doi: 10.1093/qjmed/hcy099. QJM. 2018. PMID: 29788448